Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Abuse potential and adverse cognitive effects of mitragynine (kratom)
Nurul H.M. Yusoff, Farah Wahida Suhaimi, Raja Vadivelu, et al.
Addiction Biology (2014) Vol. 21, Iss. 1, pp. 98-110
Closed Access | Times Cited: 127

Showing 1-25 of 127 citing articles:

Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users
Darshan Singh, Christian P. Müller, Balasingam Vicknasingam
Drug and Alcohol Dependence (2014) Vol. 139, pp. 132-137
Closed Access | Times Cited: 224
Following “the Roots” of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries
Eduardo Cinosi, Giovanni Martinotti, Pierluigi Simonato, et al.
BioMed Research International (2015) Vol. 2015, pp. 1-11
Open Access | Times Cited: 194
The medicinal chemistry and neuropharmacology of kratom: A preliminary discussion of a promising medicinal plant and analysis of its potential for abuse
Andrew C. Kruegel, Oliver Grundmann
Neuropharmacology (2017) Vol. 134, pp. 108-120
Closed Access | Times Cited: 187
An update on the clinical pharmacology of kratom: uses, abuse potential, and future considerations
Christopher R. McCurdy, Abhisheak Sharma, Kirsten E. Smith, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 2, pp. 131-142
Closed Access | Times Cited: 18
Kratom—Pharmacology, Clinical Implications, and Outlook: A Comprehensive Review
Steven Eastlack, Elyse M. Cornett, Alan D. Kaye
Pain and Therapy (2020) Vol. 9, Iss. 1, pp. 55-69
Open Access | Times Cited: 138
Experiences of Kratom Users: A Qualitative Analysis
Marc T. Swogger, Elaine Hart, Fire Erowid, et al.
Journal of Psychoactive Drugs (2015) Vol. 47, Iss. 5, pp. 360-367
Closed Access | Times Cited: 130
Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7‐hydroxymitragynine
Scott E. Hemby, Scot McIntosh, Francisco León, et al.
Addiction Biology (2018) Vol. 24, Iss. 5, pp. 874-885
Closed Access | Times Cited: 128
The abuse potential of kratom according the 8 factors of the controlled substances act: implications for regulation and research
Jack E. Henningfield, Reginald V. Fant, Daniel W. Wang
Psychopharmacology (2017) Vol. 235, Iss. 2, pp. 573-589
Open Access | Times Cited: 123
Prevalence and motivations for kratom use in a sample of substance users enrolled in a residential treatment program
Kirsten E. Smith, Thomas Lawson
Drug and Alcohol Dependence (2017) Vol. 180, pp. 340-348
Closed Access | Times Cited: 116
Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine
Alicia G. Lydecker, Abhisheak Sharma, Christopher R. McCurdy, et al.
Journal of Medical Toxicology (2016) Vol. 12, Iss. 4, pp. 341-349
Open Access | Times Cited: 113
Neurobiology of Kratom and its main alkaloid mitragynine
Farah Wahida Suhaimi, Nurul H.M. Yusoff, Rahimah Hassan, et al.
Brain Research Bulletin (2016) Vol. 126, pp. 29-40
Closed Access | Times Cited: 95
Kratom policy: The challenge of balancing therapeutic potential with public safety
Walter C. Prozialeck, Bonnie A. Avery, Edward W. Boyer, et al.
International Journal of Drug Policy (2019) Vol. 70, pp. 70-77
Open Access | Times Cited: 92
Abuse liability of mitragynine assessed with a self-administration procedure in rats
Kai Yue, Theresa Kopajtic, Jonathan L. Katz
Psychopharmacology (2018) Vol. 235, Iss. 10, pp. 2823-2829
Closed Access | Times Cited: 90
Understanding Kratom Use: A Guide for Healthcare Providers
Marc T. Swogger, Kirsten E. Smith, Albert Garcia‐Romeu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 52
An insight review on the neuropharmacological effects, mechanisms of action, pharmacokinetics and toxicity of mitragynine
Nur Aisyah Khairul Annuar, Ummi Kalthum Azlan, Ahmed Mediani, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116134-116134
Open Access | Times Cited: 9
Changing trends in the use of kratom (Mitragyna speciosa) in Southeast Asia
Darshan Singh, Suresh Narayanan, Balasingam Vicknasingam, et al.
Human Psychopharmacology Clinical and Experimental (2017) Vol. 32, Iss. 3
Open Access | Times Cited: 78
Mitragynine Attenuates Morphine Withdrawal Effects in Rats—A Comparison With Methadone and Buprenorphine
Rahimah Hassan, Pike-See Cheah, Sreenivasan Sasidharan, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 61
Evaluating kratom alkaloids using PHASE
Christopher R. Ellis, Rebecca Racz, Naomi L. Kruhlak, et al.
PLoS ONE (2020) Vol. 15, Iss. 3, pp. e0229646-e0229646
Open Access | Times Cited: 53
Kratom Alkaloids, Natural and Semi-Synthetic, Show Less Physical Dependence and Ameliorate Opioid Withdrawal
Lisa Wilson, Soumen Chakraborty, Shainnel O. Eans, et al.
Cellular and Molecular Neurobiology (2021) Vol. 41, Iss. 5, pp. 1131-1143
Open Access | Times Cited: 48
Oxidative Metabolism as a Modulator of Kratom’s Biological Actions
Soumen Chakraborty, Rajendra Uprety, Samuel T. Slocum, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 22, pp. 16553-16572
Open Access | Times Cited: 43
Biochemical Benefits, Diagnosis, and Clinical Risks Evaluation of Kratom
Dimy Fluyau, Neelambika Revadigar
Frontiers in Psychiatry (2017) Vol. 8
Open Access | Times Cited: 60
Pharmacologic and clinical assessment of kratom
C Michael White
American Journal of Health-System Pharmacy (2017) Vol. 75, Iss. 5, pp. 261-267
Closed Access | Times Cited: 57
Understanding the Physicochemical Properties of Mitragynine, a Principal Alkaloid of Mitragyna speciosa, for Preclinical Evaluation
Surash Ramanathan, Suhanya Parthasarathy, Vikneswaran Murugaiyah, et al.
Molecules (2015) Vol. 20, Iss. 3, pp. 4915-4927
Open Access | Times Cited: 55
Update on the Pharmacology and Legal Status of Kratom
Walter C. Prozialeck
Journal of Osteopathic Medicine (2016) Vol. 116, Iss. 12, pp. 802-809
Open Access | Times Cited: 53
Novel Psychoactive Substances—Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs
Zurina Hassan, Oliver G. Bosch, Darshan Singh, et al.
Frontiers in Psychiatry (2017) Vol. 8
Open Access | Times Cited: 52
Page 1 - Next Page

Scroll to top